Why the study?
How do patients with atrial fibrillation value different health outcomes related to stroke prevention with warfarin?
Population
57 patients over the age of 60 years with atrial fibrillation from three family practices in North-East…
Design
Cross-sectional
Authors
Loading...
Wide variation in AF utilities cautions against uniform assumptions; leaves open validation of preference-based tools in prospective studies.
How do patients with atrial fibrillation value different health outcomes related to stroke prevention with warfarin?
Patients with atrial fibrillation assign highly variable utility values to health states related to warfarin therapy and stroke, highlighting the need to consider individual preferences in decision-making.
Robinson et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: